Added to YB: 2025-08-15
Pitch date: 2025-08-12
MURA [bullish]
Mural Oncology plc
+4.07%
current return
Author Info
Clark Street Value is a special sits/event-driven investor. Sign up for the newsletter.
Company Info
Mural Oncology plc operates as a clinical-stage oncology company that focuses on discovering and developing immunotherapies for the treatment of patients with cancer.
Market Cap
$31.0M
Pitch Price
$1.72
Price Target
2.26 (+26%)
Dividend
N/A
Sector
Biotechnology
Category
special_situation
Mural Oncology: Update
MURA: $30M cap biotech with $77.1M cash ($2.50/share by Dec 2025). Higher-than-expected cash burn while winding down R&D. Hints at potential transaction in guidance language; now mentions liquidation possibility. Risk: spin-off tax status with 90% staff cuts. Target $2.26 (44% upside). Potential buyout at ~90% of projected cash.
Read full article (2 min)